Langerhans cell histiocytosis of the female genital tract: A literature review
- 1 May 2003
- journal article
- review article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 13 (3), 381-388
- https://doi.org/10.1046/j.1525-1438.2003.13204.x
Abstract
Langerhans cell histiocytosis (LCH) is a rare malignant disease involving the accumulation of a monoclonal proliferation of cells in various organs, that phenotypically resemble Langerhans cells (LC). LCH is not merely a hyperplasia of LC, as it typically affects organs that are outside of their normal physiologic distribution. Normal Langerhans cells are bone marrow-derived dendritic cells that populate the epidermis and are distinguished by the presence of Birbeck granules and cell surface protein CD1a. LC act as sentinels; they recognize, internalize, and process antigens encountered in the skin. Upon encountering an antigen, LC become activated with subsequent maturation and induction of their migratory capacity. Langerhans cells in patients with LCH are aberrant and profoundly differ from normal LC. The clinical spectrum of LCH is quite diverse; multiple organs can be affected. "Pure" genital Langerhans cell histiocytosis is a rare presentation, with only 12 previously reported cases. Due to the rarity of this disease, treatment of genital LCH is still very diverse. No modality is proven to be superior in improving patient outcome, and relapses frequently occur after surgery. Dramatic responses of cutaneous and ano-genital lesions to thalidomide and interferons have been reported. We advocate the use of immuno-modulating agents in LCH of the female genital tract first, rather than surgery.Keywords
This publication has 45 references indexed in Scilit:
- Widespread skin-limited adult Langerhans cell histiocytosis: Long-term follow-up with good response to interferon alphaClinical and Experimental Dermatology, 2002
- Langerhans cell histiocytosisAustralasian Journal of Dermatology, 2001
- Langerhans' Cell Histiocytosis on the VulvaGynecologic Oncology, 2000
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- Adult cutaneous Langerhans cell histiocytosis: remission with thalidomide treatmentBritish Journal of Dermatology, 1995
- Remission of Langerhans cell histiocytosis with thalidomide treatmentClinical and Experimental Dermatology, 1993
- Primary Langerhans Cell Histiocytosis of the VulvaGynecologic and Obstetric Investigation, 1993
- Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.The Journal of Experimental Medicine, 1992
- Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cellsImmunology Letters, 1992
- VULVAL EOSINOPHILIC GRANULOMAActa Obstetricia et Gynecologica Scandinavica, 1979